Drug Trial Radar · NCT00390780
Efficacy and Safety Study of Miconazole Lauriad to Treat Oropharyngeal Candidiasis in HIV Patients
Last checked: Nov 19, 2026Latest source record: Sep 16, 2013 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
578
Actual
Start
Jul 2006
Primary completion
Dec 2007
Study completion Jan 2008
Sponsor
- Lead sponsor
- Valerio TherapeuticsIndustry
- Sponsor type
- Industry
- First posted
- Oct 20, 2006
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to evaluate the clinical cure of miconazole Lauriad 50 mg (1x50mg) Bioadhesive buccal tablets compared with clotrimazole troches (5x10mg) after 14 days of treatment (at the test of cure visit, at Day 17-19).
Conditions
- HIV Infections
Interventions
miconazole LauriadDrug
50 mg buccal tablet once a day for 14 days
ClotrimazoleDrug
10mg troches administered Five Times a Day for 14 days
Primary outcomes
What the sponsor says the trial is designed to measure.
- Clinical Cure (Defined as a Complete Resolution of Signs and Symptoms) After 14 Days of Treatment at the Test of Cure Visit (Day 17-Day 22) Using Murray Scoring ScaleTime frame: 17 to 22 days
Locations
27 sites in 2 countries. Site status is shown where the registry gives one.
University of Alabama, Department of diagnostic Sciences School of Dentistry
Birmingham, Alabama
L.A. Gay & Lesbian center, Health & Mental, health services
Los Angeles, California
East Bay AIDS Center
Oakland, California
1401 Noth Palm Canyon
Palm Springs, California
University of Connecticut, School of dental medicine
Farmington, Connecticut
Therafirst Medical Center
Fort Lauderdale, Florida
Site not named
Fort Lauderdale, Florida
Ryan White Title III Clinic
LaBelle, Florida
University of Miami
Miami, Florida
Triple O Medical Services
West Palm Beach, Florida
Department of oral medicine and diagnostic sciences UIC college of dentistry
Chicago, Illinois
Plus Clinic, University of Maryland Dental school
Baltimore, Maryland
Henry Ford Hospital and Wayne State University, Division of infectious diseases
Detroit, Michigan
AIDS Community Research Initiative of America
New York, New York
Department Diagnostics Sciences, UNC
Chapel Hill, North Carolina
East Carolina University, Brody School of Medicine
Greenville, North Carolina
University of Oklahoma, College of medicine
Tulsa, Oklahoma
Lehigh Valley Hospital Clinical Research Department of Medicine
Allentown, Pennsylvania
Roger Williams Medical Center
Providence, Rhode Island
Bering Omega Dental Clinic
Houston, Texas
Eastern Virginia Medical Center, Center for comprehensive care of immune deficiency
Norfolk, Virginia
Downtown Infectious Disease Clinic
Vancouver, British Columbia, Canada
Providence Health Center British Columbia Centre for excellence in HIV/AIDS
Vancouver, British Columbia, Canada
Health Sciences Center
Winnipeg, Manitoba, Canada
University of Ottawa Health Services
Ottawa, Ontario, Canada
Montreal Chest Institutes immunodeficiency clinic
Montreal, Quebec, Canada
Montreal General Hospital
Montreal, Quebec, Canada
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.